Physicians Bulletin Index
Following is a list of Medicaid General and Special Bulletin articles (2000-present) that pertain specifically to Physicians.
For a complete list of articles for all providers (including articles about National Provider Identifier) refer to the Index of All Medicaid Bulletins.
- 01967 and 01996 Modifier Billing Changes, 7/05
- Mental Health and Substance Abuse Services Guidelines,
Special Bulletin IV, 12/01
- 17 Alpha Hydroxyprogesterone Caproate (17P), Injection from Bulk Powder:
- Abarelix (Plenaxis, J9999 and J0128):
- Abatacept, 250 mg (Orencia, J3590 and J0129):
- Additions to Over-the-Counter Medications Coverage List, 1/08
- Add-on Code 61795, 7/05
- Adult Care Home Prior Approval and Admissions, 8/10
- Afilbercept (Eylea – HCPCS Code J3590)
Billing Guidelines
- Affordable Care Act Enhanced Payments to Primary Care Physicians, 10/12, 11/12
- Affordable Care Act Enhanced Payments
to Primary Care Physicians: Attestation Update
- Affordable Care Act Enhanced Payments to Primary Care Physicians - UPDATE, 12/12
- Affordable Care Act Enhanced Payments to Primary Care Physicians - REVISED, 2/13
- After Hours, Weekend Visits, and On-Call Services, 8/01
- Agalsidase Beta, 35 mg (Fabrazyme, J3490) - Billing Guidelines, 8/03
- Aglucosidase Alfa (Lumizyme, HCPCS Code J3590): Billing Guidelines, 1/11
- Alefacept, 7.5 mg IV; 15 mg IM (Amevive, J3490) - Billing Guidelines, 8/03
- Alemtuzumab, 10 mg (Campath, J9010) - Billing Guidelines, 4/05
- American Dental Association (ADA) Updated for the Physician Flouride Varnish (Into the Mouths of Babes) Program, 1/07
- Aminolevulinic Acid HCI for Topical Administration, 20 %, Single Unit Dosage Form (Levulan Kerastick, J7308) - Billing Guidelines, 5/06
- Amphotericin B - Change in Billing Guidelines, 9/03
- Anticipated 2006 CPT Code Rate Changes, 1/06
- Antithrombin (Recombinant) for Injection (ATryn, HCPCS Procedure Code J3590): Billing Guidelines, 9/09
- Apligraf Coverage Criteria, 8/01
- Apligraf HCPCS Code Change, 4/02
- Apnea Monitor Coverage Criteria and Billing Guidelines, 7/02
- Apoetin Alfa
(Epogen/Procrit, HCPCS Code J0885) and Darbepoetin
Alfa (Aranesp, HCPCS Code J0881) for Non-ESRD Use: New
Billing Guidelines, 1/10
- Arsenic Trioxide, 1mg (Trisenox, J9017) – Billing Guidelines , 1/04
- Asparaginase Erwinia Chrysanthemi
(Erwinaze, HCPCS Code J9999) Billing
Guidelines, 3/12
- Attending Provider Addresses, 8/07
- Azacitidine, 25mg (Vidaza, HCPCS Code J9999) Billing Guidelines, 10/04
- Behavioral Health CPT Code Update 2013, 11/12
- Belatacept: Billing Guidelines, 11/11
- Belimumab Injection Billing Guidelines
- Bendamustine (Treanda, HCPCS Procedure Codes J9999 and J9033):
- Bendamustine Hydrochloride (Treanda, J9999):
- Bevacizumab (Avastin, J9035):
- Bevacizumab (Avastin, J9999):
- Billing Diagnostic Procedure Codes During an Inpatient Stay, 9/01
- Billing for Dental Anesthesia, 12/00
- Billing Guidelines - Revised: Pralatrexate, 6/12
- Billing Health Assessments for Refugees, 10/03
- Billing for Ocular Photodynamic Therapy with Verteporfin, 4/04
- Bortezomib, 3.5 mg (Velcade, J9999) - Billing Guidelines, 8/03
- Breast and Cervical Cancer Medicaid Procedures, 1/04
- Brentuximab Vedotin: Billing Guidelines
- C1 Esterase Inhibitor (Human) 10 units (Cinryze, Berinert HCPCS Code J0598): Billing Guidelines, 2/10
- C1 Esterase Inhibitor (Human) Injectable, 10 Units (Berinert, HCPCS Code J3590): Revised Billing Guidelines, 4/10
- C1 Esterase Inhibitor (Human) Injectable, 10 Units (Cinryze, HCPCS Code J0598): Revised Billing Guidelines, 4/10
- Cabazitaxel Injection (Jevtana, HCPCS Code J9999): Billing Guidelines, 10/10
- Calcitriol Injection, 0.1 mcg (J0636) - Billing Guidelines, 9/03
- Canakinumab Single-use Vials (180 mg) (Ilaris, HCPCS Code J3590): Billing Guidelines, 11/09
- Capsaicin 8% Patch (Qutenza, HCPCS Code J7335): Billing Guidelines, 4/11
- Care Coordination for Children, 2/11
- Care Plan Oversight (CPO) of Medicaid Home Health or Hospice Services, 9/00
- Carfilzomib (Kyprolis, HCPCS code J9999): Billing Guidelines, 10/12
- Carolina ACCESS Emergency Room Claims Paid Prior to April 18, 2000, 10/00
- Case Conference for Sexually Abused Children, 4/02
- Ceftaroline Fosamil Acetate (Telfaro, HCPCS Code J3490): Billing Guidelines, 3/11
- Centruorides Immune: Billing Guidelines, 12/11
- Certification of Need for Inpatient Hospital Care, 9/01
- Certolizumab Pegol (Cimzia, HCPCS Procedure Code J3590) - Billing Guidelines, 8/08
- Cetuximab (Erbitux, J9055) - Update to Billing Guidelines, 8/06
- Cetuximab (Erbitux, J9999) - Billing Guidelines, 6/04
- Change in FL2 and MR2 Process, 07/01
- Change in Reimbursement Rates for Injectable Immunization Administration Codes:
- Change to Injectable Drug List, 3/00
- Changes in Drug Rebate Manufacturers:
- Childbirth Education Policy Revision, 8/08
- Circumcision Updates, 10/09
- Claims Denials Related to Fetal Nuchal Translucency Measurement, 10/08
- Clarification for Seminar Attendees, 12/04
- Clarification of the January 2000 Bulletin Article “Reimbursement Rate: Physician Fees”, 1/01
- Clarification of Prior Approval Guidelines for Inpatients Applying for Medicaid During a Psychiatric Hospital Stay, 9/00
- Clarification Regarding Psychiatric Billing, 7/12
- Clarification of the Two-Step Tuberculosis (TB) Test Process and Billing, 12/09
- Clarification on Individual and Group Enrollment and Reporting Changes to Medicaid, 2/09
- CLIA Certification Related Claim Denials:
- Clinical Coverage Policy Updates, 2/11
- Coagulation Factor VIII Complex/von Willebrand Factor (Human) (Wilate, HCPCS Code J3590): Billing Guidelines, 5/10
- Code Change for Gastric Bypass Surgery, 2/05
- Collagenase Clostridium Histolyticum Injectable (Xiaflex, HCPCS Code J3590): Billing Guidelines, 5/10
- Compounded Hydroxyprogesterone Caproate, 7/11
- Correction to "Drugs Added to the Physician's Drug Program Billing Guidelines" Nelarabine (Arranon) - HCPCS Procedure Code J9261, 2/08
- Correction to Injectable Drug List, 5/00
- Coverage Criteria for Implantation of Patient-activated Cardiac Event Recorder, 4/00
- Coverage of Apligraf, Q0185, 1/01
- Coverage of New HCPCS "G" Codes for End-Stage Renal Disease Related Services, 7/04
- CPT Procedure Code 90761, 9/06
- Cytarabine Liposome (DepoCyt, HCPCS Procedure Code J9098) - Billing Guidelines, 8/07
- Daptomycin Injection, 1 mg (Cubicin, K0878) - Billing Guidelines, 5/06
- Darbepoetin Alfa, 5 mcg (Aranesp, J0880) – Billing Guidelines, 3/03
- Deflux Injectable Gel for the Treatment of Standard Vesicoureteral Reflux - Coverage Notice, 8/04
- Degarelix Single-use Vials for Injection (Firmagon, HCPCS Procedure Code J3490): Billing Guidelines, 9/09
- Denials for New Patient Eye Exams, 11/08
- Denosumab Injection (Prolia, HCPCS Code J3590): Billing Guidelines, 9/10
- Denosumab (Xgeva, HCPCS Code J3590): Billing Guidelines, 3/11
- Dermagraft Coverage (J7324), 4/05
- Dexamethasone Implant, Intravitreal, 0.1 mg, 8/11
- Dexamethasone Implant, Intraviteral (Ozurdex, HCPCS Code J3490): Billing Guidelines, 2/10
- Dexrazoxane (Totect, HCPCS Procedure Code J3490) - Billing Guidelines, 4/08
- Dietary Evaluation and Counseling, 1/08
- Doripenem (Doribax, HCPCS Procedure Code J3490) - Billing Guidelines, 4/08
- Drugs Added to the Physicians Drug Program Billing Guidelines, 1/08
- Durable Medical Equipment Prescriptions and Certificate of Medical Necessity and Prior Approval Forms, 3/03
- Ecallantide Injectable (Kalbitor, HCPCS Code J3490): Billing Guidelines, 5/10
- Eculizumab, 300mg/30ml single-use vial (Soliris, J3590) Billing Guidelines, 6/07
- Emergency Medical Screening Examinations, 5/02
- Endoscopic Retrograde Cholangiopancreatography, 6/08
- Epoetin Alfa (Epogen/Procrit, HCPCS Code J0885) and Darbepoetin Alfa (Aranesp, HCPCS Code J0881): New Billing Guidelines, 12/10
- Epogen for End-Stage Renal Disease - Changes to Billing Guidelines:
- Eribulin Mesylate (Halaven, HCPCS Code J9999): Billing Guidelines, 3/11
- Essure Permanent Sterilization Procedure - Coverage Notice, 8/04
- Etonogesterel, 68-mg Implant (Implanon, HCPCS Procedure Code J3490) Billing Guidelines, 11/06
- Extracorporeal Membrane Oxygenation, 7/05
- Factor VIIa (Coagulation Factor, Recombinant) per 1.2 mg (Novoseven, Q0187) –Billing Guidelines, 2/03
- Factor VIII (Xyntha, HCPCS Procedure Code Q2023): Billing Guidelines, 7/09
- Ferrlecit (Sodium Ferric Gluconate Complex in Sucrose, HCPCS Code J2916, 12.5 mg Injection) - Billing Guidelines, 10/03
- Ferrlecit (Sodium Gluconate Complex, HCPCS Code J2915, 625 mg.) Coverage Criteria, 1/02
- Ferumoxytol Injection (Feraheme, HCPCS Procedure Code J3490): Billing Guidelines, 10/09
- Fibrinogen Concentrate (Human) Single-use Vials for Injection (RiaSTAP, HCPCS Procedure Code J3590): Billing Guidelines, 9/09
- Fondaparinux Sodium Injectable 0.5 mg (Arixtra, HCPCS Code J1652): Billing Guidelines, 2/10
- Fosaprepitant Dimeglumine (Emend, HCPCS Procedure Code J3490) - Billing Guidelines, 4/08
- Fulvestrant, 250mg/5ml (Faslodex, J9999) – Billing Guidelines, 2/03
- Gastric Bypass Prior Approval Documentation, 10/05
- Gemtuzumab Ozogamicin, 5mg (Mylotarg, J9300) Billing Guidelines, 10/04
- Golimumab (50 mg per 0.5 ml) for Injection (Simponi, HCPCS Procedure Code J3590): Billing Guidelines:
- Hyaluronan or Derivative, Gel-One, for Intra-Articular Injection: Billing Guidelines for PDP, 5/13
- HCPCS Code Changes for Radiopharmaceutical Agents, 1/06
- HCPCS Code Changes for the Physician's Drug Program:
- HCPCS Code A4550, 2/05
- Hemin, 1mg (Panhematin, HCPCS Procedure Code 1640) - Billing Guidelines, 10/08
- HIPAA Code Conversion, Special Bulletin IV, August 2002
- Histrelin Acetate (Supprelin LA, J3490) Billing Guidelines, 9/07
- Human Thrombin Topical Protein (Evithrom, HCPCS Procedure Code J3590) - Billing Guidelines, 4/08
- Human Thrombin Topical Protein, Preservative-Free (Recothrom, HCPCS Procedure Code J3590) - Billing Guidelines, 4/08
- Hyaluronan or Derivative, Gel-One, for Intra-Articular Injection: Billing Guidelines for PDP, 5/13
- Hydroxocobalamin, 5 gram kit (Cyanokit, J3490) Billing Guidelines, 6/07
- Hydroxyprogesterone Caproate (Makena, HCPCS Code J3490): Billing Guidelines, 4/11
- Hyperbaric Oxygenation Therapy: Approval for Urgent Treatment, 7/05
- Ibandronate Sodium 3-mg/3-ml injection (Boniva, HCPCS Procedure Code J3490) Billing Guidlines, 12/06
- Idursulfase/Elaprase (HCPCS Procedure Code J3490) - Billing Guidelines, 3/07
- Immune Globulin (IgIV, Human, for Intravenous Use, CPT 90283) Coverage Clarification, 9/01
- Immune Globulin Intravenous Injection (J1563, 1 gm and J1564, 10 mg) - Billing Guidelines, 9/03
- Immune Globulin, Non-lyophilized Intravenous (Privigen, J3590) - Billing Guidelines, 4/08
- Immune Globulin Subcutaneous (Human) Injectable (Hizentra, HCPCS Code J3590): Billing Guidelines, 6/10
- Implantable Contraceptive Capsules, 5/00
- “Incident to Service” Policy Expanded to Include Licensed Psychological Associates, 5/01
- Incident to Policy for Licensed Clinical Social Workers and Clinical Nurse Specialists, 8/00
- Individual Visits, 8/00
- Infliximab (Remicase, HCPCS Code J1745) and Rituximab (Rituxan, HCPCS Code J9310): New Billing Guidelines, 11/09
- Injectable Drug Coverage through the Pharmacyand Physician’s Drug Programs, 4/03
- Injectable Drug Fee Change, 5/00
- Injectable Drug List Update, 6/02
- Injection, Ertapenem Sodium, 500 mg (Invanz, HCPCS Procedure Code J1335) Billing Guidelines, 11/06
- Injection, Factor X111 Concentrate, 9/11
- Injection, Icatibant Acetate: Billing Guidelines, 12/11
- Injection, Von Willebrand Factor
Complex (Human), Wilate, 8/11
- Interferon Beta-1a (Avonex, HCPCS Procedure Code Q3025): Billing Guidelines, 8/09
- Interferon Beta-1b Injectable (Extavia, HCPCS Code J1830): Billing Guidelines, 2/10
- Interpreter Signature on Sterilization Consent Form, 4/00
- Into the Mouths of Babes: Oral Screening and Flouride Varnish Program, 05/05
- Intrauterine Devices Billable on the CMS-1500 Claim Form - Reimbursement Rates, 6/04
- Introduction to Medicaid's Uniform Screening Program - A Web-Based System Set for Implementation in October 2007, 5/07
- Ipilimumab Injection Billing Guidelines, 6/11
- Ixabepilone Kit for Injection (Ixempra) - Billing Guidelines, 8/08
- Ixabepilone Kit for Injection (Ixempra, HCPCS Procedure Code J3490) - Billing Guidelines, 4/08
- Lacosamide Single-Use Vials for Injection (Vimpat, HCPCS Procedure Code J3490): Billing Guidelines, 7/09
- Lanreotide Injection (Somatuline Depot, HCPCS Procedure Code J3490) - Billing Guidelines, 4/08
- Laronidase, 2.9 mg/5 ml (Aldurazyme, J3490) - Billing Guidelines, 8/03
- Leuprolide Acetate Implant, 65mg (Viadur, J9219) – Billing Guidelines, 2/03
- Leuprolide Acetate Injectable (HCPCS Procedures Codes): Change in Billing Guidelines, 10/09
- Levetiracetam, 500-mg/5ml Injection (Keppra, HCPCS Procedure Code J3490) Billing Guidelines, 11/06
- Lidocaine for Topical Anesthesia and Saline/Water Codes: Billing Guidelines, 12/09
- Linezolid, 200mg (Zyvox, J2020) Billing Guidelines, 7/07
- Lymphocyte Immune Globulin, Antithymocyte Globulin, Equine, Parenteral, 250 mg (Atgam, J7504) Billing Guidelines, 4/06
- Makena Billing Guidelines Revised for the Physician's Drug Program , 7/11
- Medicaid Fee Schedule, 10/01
- Medical Risk Management Project, 3/09
- Medication Administration Codes, 5/00
- Medroxyprogesterone Acetate/Estradiol Cypionate, 5 mg/25 mg (Lunelle, HCPCS Code J1056) – Billing Guidelines, 4/03
- Mental Health and Substance Abuse Services Guidelines, Special Bulletin IV, December 2001
- Methyl Aminolevulinate (MAL) for Topical Administration, 16.8%, 1 Gram (Metvixia, HCPCS Code J7309): Billing Guidelines, 4/11
- Mirena (Levonorgestrel-Releasing Intrauterine System, Code J7302) Coverage Criteria, 3/02
- Miscellaneous Supplies, 6/02
- Modifier YR – Routine Foot Care, 11/02
- Modifier YS for Teleconsults, 1/03
- Natalizumab (Tysabri, HCPCS Procedure Code J2323) - Update to Billing Guidelines, 5/08
- Natalizumab, 300 mg (Tysabri, J3490) Billing Guidelines, 3/05
- National Drug Codes:
- Neonatal Intensive Care Services, 5/02
- New Codes for the Oral Screening Preventive Package for Use in Primary Care Physician Offices, 8/02
- New Guidelines for Enrollment:
- New Oral Screening Preventive Package for Use in Primary Care Physician Offices, 1/01
- New Procedures for Submitting Sterilization
Consent Forms to EDS, 9/01
- Norplant Insertion Kit, 10/00
- Obstetric Add-Ons, 9/07
- Obstetrical Ultrasounds for Multiple Fetuses, 5/05
- Octreotide Acetate, 1 mg (Sandostatin LAR Depot, J2352) – Clarification to Billing Guidelines, 4/03
- Ocular Photodynamic Therapy with Verteporfin - Revised Billing Guidelines, 7/04
- Ofatumumab Injectable (Arzerra, HCPCS Code J9999): Billing Guidelines, 2/10
- Olanzapine Injectable (Zyprexa Relprevv, HCPCS Code J3490, and Zyprexa, HCPCS Code S0166): Billing Guidelines, 5/10
- Omalizumab (Xolair, J3490) – Billing Guidelines, 1/04
- Omalizumab, 5 mg (Xolair, HCPCS Code J2357): Change in Coverage, 4/11
- Oral Screening and Preventive Package Update, 11/07
- Oral Screening Preventive Package Update, 10/01
- Orthotic and Prosthetic Devices in the Office:
- Out-of-State Prior Approval Procedure for Acute and Rehabilitation Hospital Care, 10/00
- Outpatient Behavioral Health:
- Outpatient Observation Charges for Hysterectomies, 11/04
- Outpatient Specialized Therapies:
- Addition of V Code Diagnosis for Outpatient Specialized Therapies, 5/03
- Changes to Outpatient Specialized Therapies: 12/08; 10/09; 11/09
- Clarification of Billing Instructions for Outpatient Specialized Therapies, 6/03
- Clarification of First Treatment for Outpatient Specialized Therapies, 9/05
- Correction to V Code Diagnosis for Outpatient Occupational Therapy Services, 7/03
- Documentation Standards, 12/10
- Electronic Submission Process for Prior Authorization Requests, 7/06
- Outpatient Specialized Therapies, 9/09
- Outpatient Specialized Therapies CCNC Pilot Project, 6/05
- Outpatient Specialized Therapies and Independent Practitioners Medical Coverage Policy Revisions, 4/03
- Outpatient Specialized Therapies, Special Bulletin V, September 2002
- Post-Payment Validation, 4/10
- Post-Payment Validation Review “Helpful Hints”, 9/10
- Prior Approval of Outpatient Specialized Therapy Services [Workshop], 8/02
- Prior Approval Process: 4/02; 5/02; 4/03; 11/03; 5/04
- Prior Authorization and Post-Payment Validation, 3/10
- Prior Authorization Process - Update to New Web Site and Submission Process, 10/06
- Prior Authorization Process – Post Payment Validation, 6/07
- Prior Authorization Process - Post-Payment Validation Begins August 2007, 7/07
- Prior Authorization Process: Survey Results, 6/08
- Prior Authorization Process - New Fax Forms, 2/07
- Prior Authorization Process - Web Site Registration, 1/07
- Prior Authorization Process - Implementation Date for Electronic Submission and New Forms, 12/06
- Respiratory Therapy Criteria, 7/03
- Revision to Rates for Occupational Therapy, Physical Therapy, Respiratory Therapy, and Audiology Services, 5/05
- Updates to Outpatient Specialized Therapies Prior Approval Process, 7/05
- Video Conference Seminars:
- Web-based Survey for Prior Authorization Website, 3/08
- Oxaliplatin, 7/11
- Oxaliplatin (Eloxatin, HCPCS Procedure Code J9263) - Additional Diagnosis Codes:
- Oxaliplatin, 50 mg (Eloxatin, J9999) - Billing Guidelines, 9/03
- Paclitaxel Protein-bound Particles for Injectable Suspension, 1mg (Abraxane, J9999) - Billing Guidelines, 9/05
- Paliperidone Palmitate Exended Release, 1 mg (Invega Sustenna,HCPCS Code J2426): Billing Guidelines, 4/11
- Palonosetron 0.25 mg (Aloxi, J3490) – Billing Guidelines, 1/04
- Pantitumumab, 20 mg/ml Injectable (Vectibix, J999) Billing Guidelines, 1/07
- Patient Demand Single or Multiple Event Recording CPT 93268, 7/00
- Pegaptanib, 0.3 mg (Macugen, J3490) - Billing Guidelines, 4/05
- Pegfilgrastim, 6mg (Neulasta, S0135) – Billing Guidelines, 2/03
- Pegloticase (Krystexxa, HCPCS Code J3590): Billing Guidelines, 3/11
- Peginterferon Alfa-2B Injection Billilng Guidelines, 7/11
- Pegylated Interferon Alfa-2b, 10 mcg (PEG-Intron, HCPCS Procedure Code J3590) Billing Guidelines, 11/06
- Peinterferon Alfa - 2a, 180 mcg/ml (Pegasys, J3490 and S0145) - Billing Guidelines, 5/06
- Pemetrexed (Alimta, J9999 and J9305):
- Phase II Outpatient Cardiac Rehabilitation, 9/08
- Physical and Occupational Therapy Evaluations, 6/00
- Physician Assistant Enrollment, 9/11
- Physicians Billing for CPT Procedure Codes 15832-15837, 7/11
- Physicians Billing for CPT Procedure Code 16035, 7/11
- Physician Management of ESRD - Code Changes and Billing Guidelines for CMS-1500, 10/04
- Physician Referral Form for HIV Case Management Services, 2/11
- Physician's Drug Program List Update:
- Physicians Drug Program Pricing Update:
- Plan B Product Coverage, 2/07
- Plerixafor, 1.2 ml Single-use Vials for Injection (Mozobil, HCPCS Procedure Code J3490) Billing Guidelines, 3/09
- Plerixafor Injection (Mozobil, HCPCS Procedure Code J3490) - Correction to Reimbursement Rate, 4/09
- Pralatrexate Injectable (Folotyn, HCPCS Code J9999): Billing Guidelines, 2/10
- Preadmission Screening and Annual Resident Review Seminars, 3/00
- Pre-Dialysis ESRD Focused Care Study, 3/09
- Pregnancy Care Management Services, 2/11
- Pregnancy Medical Home Project Seminars:
- Prescribing and Documenting Brand
Medically Necessary Drugs, 6/12
- Prior Approval and Medicare, 10/04
- Prior Approval for Non-Emergency Out-of-State Services, 6/03
- Prior Authorization for CPT Procedure Codes 99408 and 99409 Provided by Provissionally Licensed Providers Billing "Incident To" a Physician, 7/09
- Procedure for Reporting Changes in Provider Status, 5/01
- Progestacert IUD, W5142 Now End-dated, 4/03
- Proposed Obstetrical Ultrasound Requirements, 8/10
- Protein C Concentrate (Human) (Ceprotin, J3590) Billing Guidelines, 9/07
- Provider Enrollment Directly through DMA, 10/04
- Provider Enrollment, 10/05
- Provider Enrollment, Billing, and Coverage Information, 1/05
- Purchasing Drugs for Administration in a Provider's Office, 9/03
- Radiopharmaceuticals Used in Myocardial Perfusion Imaging and Echocardiography, 8/01
- Ranibizumab, 0.5 mg Injectable (Lucentis, HCPCS Procedure Code J3590) Billing Guidelines, 11/06
- Ranibizumab (Lucentis, HCPCS Code J2778): Update to Billing Guidelines, 10/10, 11/12
- Rasburicase, 0.5 mg (Elitek, HCPCS Procedure Code J2783), 3/09
- Rate Increase for Physician Fluoride Varnish Services, 9/08
- Reduction Mammaplasty, 8/01
- Referrals for Outpatient Behavioral Health Services, 2/13, 3/13
- Regadenson (Lexiscan) Billing Guidelines, 6/09
- Reimbursement for Asthma Equipment and Supplies, 10/09
- Reimbursement Rate: Physician Fees, 1/00
- Reporting of Never Events and Hospital-Acquired Conditions
- Requesting an Exception to the Legislative Visit Limit, 9/09
- Requesting Changes to the Pharmacy Opt-in Provider, 2/08
- Resident Supervision Requirements in Teaching Hospitals and Residency Programs, 6/00
- Rho (D) Immune Globulin for Intravenous Use (CPT Code 90386) – Billing Guidelines, 6/01
- Rilonacept (Arcalyst, HCPCS Code J2793): Billing Guidelines, 2/10
- Risperidone (Risperdal Consta, J3490) – Billing Guidelines, 1/04
- Romidepsin, 1 mg (Istodax, HCPCS Code J9315): Billing Guidelines, 4/11
- Romiplostim (Nplate, HCPCS Procedure Code J3490) - Billing Guidelines, 12/08
- Service Billing Guidelines for End-Stage Renal Disease for Undocumented Aliens and Deceased Recipient, 5/07
- Sildenafil Injectable (Revation, HCPCS Code J3490): Billing Guidelines, 5/10
- Sodium Fluoride F-18 (HCPCS Procedure Code A9580) - Billing Guidelines, 6/09
- SPECIAL BULLETIN - 1915 (b)/(c) Waiver Expansion in Coastal Care, 2/13
- SPECIAL BULLETIN - 1915 (b)/(c) Waiver Expansion in CoastalCare, 1/13
SPECIAL BULLETIN - 1915 (b)/(c) Waiver Expansion in MeckLINK, 2/13
- SPECIAL BULLETIN - 1915 (b)/(c) Waiver Expansion, 1/13 SUPERSEDED BY SPECIAL BULLETIN - 1915 (b)/(c) Waiver Expansion In Mecklenburg County, 1/13
- SPECIAL BULLETIN - Behavioral Health CPT© Code Changes for Psychotherapy and Psychodiagnostic Interviewing; Addition of Outpatient Crisis Services, 1/13
- SPECIAL BULLETIN - Termination of Western Highlands Network Management of the 1915 b/c Waivers, 4/13
- SPECIAL BULLETIN - Transition to 1915(i) Personal Assistance Services, 6/12
- Stem Cell Transplants-Prior Approval Effective Dates, 11/04
- Sterilization Consent Forms and Hysterectomy and Abortion Statements, 10/09
- Submission of Prior Approval Requests for Transplants, 7/05
- Surgery of the Lingual Frenulum, 4/04
- Synagis Coverage for 2004-2005, 9/04
- Systematic Reprocessing of Specialized Therapy Adjustments, 2/06
- Telavancin Injectable (Vibativ, HCPCS Code J3490): Billing Guidelines, 2/10
- Temozolomide Single-use Vials for Injection (Temodar, HCPCS Procedure Code J9999): Billing Guidelines, 9/09
- Temsirolimus (Torisel, J3490) Billing Guidelines, 9/07
- Testosterone Pellets (Testopel, HCPCS Procedure Code S0189) - Billing Guidelines, 4/09
- Tigecycline, 1 mg (Tygacil, HCPCS Code J3243): Billing Guidelines, 4/11
- Tocilizumab Injectable (Actemra, HCPCS Code J3590): Billing Guidelines, 5/10
- Triptorelin Pamoate (Trelstar Depot and Trelstar LA, J3315) Billing Guidelines, 8/06
- Update to Approve Procedures for Ambulatory Services and Physicians, 5/06
- Updates to Recommended Referral Forms for Use Between Primary Care and Behavioral Health Providers, 2/13
- Upper and Lower Extremity Compression Sleeves, 2/01
- Use of Locem Tenens When Called to Active Duty in the Armed Forces, 5/08
- Ustekinumab Injectable (Stelara, HCPCS Code J3590): Billing Guidelines, 2/10
- Varicella-Zoster Immune Globulin, Human, for Intramuscular Use (CPT 90396), Billing Guidelines, 8/02
- Velaglucerase Alfa Injectable (VPRIV, HCPCS Code J3590): Billing Guidelines, 6/10
- Venofer (Iron Sucrose Injection, HCPCS Codes J1755 and J1756) - Billing Guidelines, 10/03
- Vitrasert (Ganciclovir, 4.5 mg, Long-acting Implant, Code J7310), 7/02
- Zemplar (Paracalcitrol, HCPCS Code J2501, 1 mcg Injection) - Billing Guidelines, 10/03
- Ziconotide Intrathecal, 25mcg/ml and 100mcg/ml (Prialt, J3490) - Billing Guidelines, 4/05
- Ziv-aflibercept (Zaltrap), HCPCS code J9999): Billing Guidelines, 11/12
- Zoledronic Acid, 1mg (Reclast, Q4095) Billing Guidelines, 7/07
- Zoledronic Acid (Reclast, HCPCS Code J3488): Update to Billing Guidelines, 10/10
